Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Flyvbjerg

Showing results (131-140 of 253) with videos related to

Pageof 26
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Effects of 12 months of GH treatment on cortical and trabecular bone content of IGFs and OPG in adults with acquired GH deficiency: a double-blind, randomized, placebo-controlled studyThor Ueland, J Bollerslev, A Flyvbjerg, et al.
Kidney International|December 14, 1999
Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failureJ Frystyk, P Ivarsen, C Skjaerbaek, et al.
The Journal of Clinical Endocrinology and Metabolism|November 30, 2000
Stimulation of the 150-kilodalton insulin-like growth factor-binding protein-3 ternary complex by continuous and pulsatile patterns of growth hormone (GH) administration in GH-deficient patientsT Laursen, A Flyvbjerg, J O Jørgensen, et al.
Endocrinology|September 29, 1998
Developmental changes in serum levels of free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit in ratsJ Frystyk, H Grønbaek, C Skjaerbaek, et al.
Diabetologia|May 3, 2007
Mannose-binding lectin deficiency attenuates renal changes in a streptozotocin-induced model of type 1 diabetes in miceJ Østergaard, S Thiel, M Gadjeva, et al.
Anticancer Research|March 2, 2005
Growth hormone receptor antagonist administration inhibits growth of human colorectal carcinoma in nude miceF Dagnaes-Hansen, H Duan, L M Rasmussen, et al.
Diabetes|May 20, 1999
Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in miceA Flyvbjerg, W F Bennett, R Rasch, et al.
The American Journal of Physiology|May 1, 1997
Effect of GH/IGF-I deficiency on long-term renal changes and urinary albumin excretion in diabetic dwarf ratsH Grønbaek, P Volmers, S F Bjørn, et al.
The American Journal of Gastroenterology|April 2, 2002
Low free and total insulinlike growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatmentH Grønbek, T Thøgersen, J Frystyk, et al.
Transplantation Proceedings|April 1, 1993
IGF-1 and acute renal hypertrophy: inhibition by somatostatin analoguesH Orskov, A Flyvbjerg, J Frystyk, et al.
Pageof 26

Showing results (131-140 of 253) with videos related to

Sort By:
Pageof 26
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Effects of 12 months of GH treatment on cortical and trabecular bone content of IGFs and OPG in adults with acquired GH deficiency: a double-blind, randomized, placebo-controlled studyThor Ueland, J Bollerslev, A Flyvbjerg, et al.
Kidney International|December 14, 1999
Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failureJ Frystyk, P Ivarsen, C Skjaerbaek, et al.
The Journal of Clinical Endocrinology and Metabolism|November 30, 2000
Stimulation of the 150-kilodalton insulin-like growth factor-binding protein-3 ternary complex by continuous and pulsatile patterns of growth hormone (GH) administration in GH-deficient patientsT Laursen, A Flyvbjerg, J O Jørgensen, et al.
Endocrinology|September 29, 1998
Developmental changes in serum levels of free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit in ratsJ Frystyk, H Grønbaek, C Skjaerbaek, et al.
Diabetologia|May 3, 2007
Mannose-binding lectin deficiency attenuates renal changes in a streptozotocin-induced model of type 1 diabetes in miceJ Østergaard, S Thiel, M Gadjeva, et al.
Anticancer Research|March 2, 2005
Growth hormone receptor antagonist administration inhibits growth of human colorectal carcinoma in nude miceF Dagnaes-Hansen, H Duan, L M Rasmussen, et al.
Diabetes|May 20, 1999
Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in miceA Flyvbjerg, W F Bennett, R Rasch, et al.
The American Journal of Physiology|May 1, 1997
Effect of GH/IGF-I deficiency on long-term renal changes and urinary albumin excretion in diabetic dwarf ratsH Grønbaek, P Volmers, S F Bjørn, et al.
The American Journal of Gastroenterology|April 2, 2002
Low free and total insulinlike growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatmentH Grønbek, T Thøgersen, J Frystyk, et al.
Transplantation Proceedings|April 1, 1993
IGF-1 and acute renal hypertrophy: inhibition by somatostatin analoguesH Orskov, A Flyvbjerg, J Frystyk, et al.
Pageof 26